RedDress Announces Randomized Controlled Trial Results Showing Significant Benefits of ActiGraft Pro for Diabetic Foot Ulcers Patients treated with ActiGraft Pro from RedDress are more than twice as likely to heal compared with those receiving standard of care per a new study.

Arch Therapeutics Provides Year End Operational Update Fiscal year-end AC5 Advanced Wound System update includes Q4 record monthly order volumes, favorable reimbursement decisions and increases in paid claims.

Advanced Wound Care Market Size & Share to Surpass $14.69 Billion by 2030 | Vantage Market Research WASHINGTON, Aug. 22, 2023 (GLOBE NEWSWIRE) -- According to a report published by Vantage Market Research, The Global Advanced Wound Care Market was valued at USD 9.50 Billion in 2022 and is forecast...

Vaporox Announces FDA Clearance for Its Next Generation Wound Care Medical Device DENVER, March 27, 2023 (GLOBE NEWSWIRE) -- Vaporox, a Denver based medical device company, has received clearance from the US Food and Drug Administration for its next generation VHT-200 medical...